Therapeutic type & products | Disorder/disease | Lactococcus lactis strain | References |
---|---|---|---|
Cytokines/ligands | |||
 Interleukin-6 (IL-6) | Adjuvant | IL1403 | [123] |
 Interleukin-10 (IL-10) | Adjuvant, hypersensitivity type I, inflammatory bowel disease (IBD) | N/S | |
 Interleukin-12 (IL-12) | Adjuvant; hypersensitivity type I; asthma | NZ9000 | |
 Interleukin-18 (IL-18) | Adjuvant, immunomodulatory, | MG1363 | [124] |
 Hemagglutinin-neuraminidase (HN) protein of NDV | Breast cancer | NZ9000 | [33] |
 RANKL | Cancer vaccine adjuvant | IL1403 | [84] |
 Transforming growth factor beta 1 (TGF-β1) | IBD | NZ9000 | [82] |
 Epidermal growth factor (EGF) Trefoil factor 3 (TFF3) | Wound healing | NZ9000 | [125] |
 Kisspeptin (KiSS 1) | Colorectal cancer | NZ9000 | [88] |
 Insulin-like growth factor I (IGF-I) | Colitis | NZ9000 | [83] |
Allergens | |||
 Peanut allergen (Ara 2) | Hypersensitivity type I | CHW9 | [85] |
 Birch allergen (Bet v1) | Hypersensitivity type I | NZ9800 | [86] |
 House dust mite allergen (Der p2) | Hypersensitivity type I | NZ9000 | [87] |
Enzymes | |||
 Subtilisin QK-2 | Thrombosis | NZ9000 & NZ3900 | [36] |
 Heme oxygenase-1 (rmHO-1) | Acute colitis | NZ9000 | [126] |
Vaccines/antigens | |||
 Tetanus toxin fragment C (TTFC) | Tetanus | UCP1054 | |
 HPV-16-E7 | HPV-16 induced cancers | NZ9000 | |
 Pneumoccal antigen | Pneumococcal infections, meningitis | N/S | |
 Listeriolysin O & mt Internalin A | Listeriosis | NZ9000 | [34] |
 Glycosylated tyrosinase related protein-2 (TRP-2) | Skin cancer | MG1363 | [102] |
 Carcinoembryonic antigen (CEA) | Colon cancer | NZ9000 | [127] |
 Plasmodium falciparum recombinant antigen (R0.10C) | Malaria | N/S | [105] |
 Influenza virus nucleoprotein (NP) | Influenza | NZ9000 | [128] |
 Shigella IpaB and IpaD | Shigellosis | PA1001 | |
 Neuraminidase (NA1) | Avian influenza H5N1 | NZ3000 | |
 Hemagglutinin (HA1) | Avian influenza H5N1 | NZ9000 | [111] |
 Hemagglutinin (HA1) | Avian influenza H1N1 | NZ9000 | [112] |
 M2e antigen | Avian influenza H5N2 | LM2301 | [113] |
 IBV multi-epitope geneEpiC | Avian bronchitis | NZ3900 | [114] |
 Campylobacter rCjaAD antigen | Avian gastroenteritis | IL1403 | [115] |
 GroEL, heat-shock protein | Brucelosis | NZ9000 | [116] |
 Cu–Zn SOD of Brucella abortus | Brucelosis | NZ9000 | [129] |
 Mycobacterial ESAT-6 antigen | Tubercolosis | N/S | [117] |
 D1 and D4 aerolysin | Aeromonas spp. infection | Lac-D1ae | [118] |
 SiMA antigen | Streptococcal infection | BFE920 | |
 Myelin epitopes | Multiple sclerosis, encephalomyelitis | IBB360 | [130] |
 T1D autoantigens | Type-1 diabetes mellitus | N/S | [131] |
 Enterohemorrhagic Escherichia coli (EHEC) antigen (EspB) | EHEC infection | N/S | [132] |
 Multi-urease epitopes (CTB-UE) | Helicobacter pylori infection | NZ9000 | [133] |
 Helicobacter pylori hspA | Helicobacter pylori infection | NZ3900 | [71] |
 HIV-1 Gag-p24 | Human immunodeficiency virus (HIV) infection | N/S | [134] |
 Capsid protein of porcine circovirus type 2 (PCV2) | Swine circovirus associated disease | N/S | [135] |
 Staphylococcus aureus HtrA protease | Staphylococcal infection | IL1403 | [136] |
 Staphylococcus aureus clumping factor A (ClfA) | Staphylococcal infection | N/S | [137] |
 Hepatitis E virus antigen | Hepatitis E virus infection | NZ3900 | [138] |
 Toxin A/B (TcdA/B) | Clostridium difficile infection | N/S | [139] |
 F and G glycoproteins of Respiratory syncytial virus | Upper respiratory tract infection | NZ9000 | [140] |
Others | |||
 HSP65-6IA2P2 | Type 1 diabetes mellitus | NZ9000 | [90] |
 Gamma-amino butyric acid (GABA) | Hypotensive, anti-cancer, anti-anxiety | All ssp. Lactis | [93] |
 Bacillus thuringiensis crystal protein Cry5B | Anthelminthic | NCK203 | [89] |
 Serine protease inhibitors | IBD | NZ9000 | [82] |
 Glucagon like peptide-1 (GLP-1) | Type 2 diabetes mellitus | N/S | [141] |